Wheeler Amanda, Humberstone Verity, Robinson Gail
Clinical Research and Resource Centre, Mental Health Services and Community Alcohol and Drug Services, Waitemata District Health Board, Auckland, New Zealand.
Australas Psychiatry. 2006 Jun;14(2):169-74. doi: 10.1080/j.1440-1665.2006.02273.x.
This study describes antipsychotic prescribing practices for outpatients with schizophrenia over a 3 year period in two large mental health catchment areas of Auckland.
All community files were reviewed at three time points. Patient characteristics, diagnosis and antipsychotic treatment information were recorded and analysed.
Over the three time periods, the number of outpatients with a diagnosis of schizophrenia or schizoaffective disorder was stable. There was a marked change in the type of antipsychotic prescribed, with an 18.6% increase in atypical antipsychotics and a decrease in both intramuscular and oral typical antipsychotics. Clozapine was the most commonly prescribed antipsychotic in 2003 (35%). Despite the fact that polypharmacy was relatively low (14.6% in 2003), those receiving more than one antipsychotic had a greater likelihood of being prescribed a higher total daily dose.
This study describes a change in antipsychotic prescribing towards recommended practice guidelines for the treatment of schizophrenia over a 3 year period.
本研究描述了奥克兰两个大型心理健康服务区域内,为期三年的精神分裂症门诊患者抗精神病药物的处方用药情况。
在三个时间点对所有社区档案进行审查。记录并分析患者特征、诊断及抗精神病治疗信息。
在这三个时间段内,被诊断为精神分裂症或分裂情感性障碍的门诊患者数量保持稳定。所开具的抗精神病药物类型有显著变化,非典型抗精神病药物增加了18.6%,而肌肉注射和口服典型抗精神病药物均有所减少。氯氮平是2003年最常开具的抗精神病药物(35%)。尽管联合用药比例相对较低(2003年为14.6%),但接受多种抗精神病药物治疗的患者更有可能被开具更高的每日总剂量。
本研究描述了三年来抗精神病药物处方用药向精神分裂症治疗推荐实践指南的转变。